期刊文献+

抗炎药物喜树碱的衍生化修饰 被引量:1

The modifier of anti-cancer camptothecin derivatives
下载PDF
导出
摘要 目的为了增强喜树碱溶解性和提高它的抗肿瘤活性。方法采用了新颖的由喜树碱合成7-乙基喜树碱的路径,在此基础上利用阿司匹林对其20S-羟基酯化,并利用核磁共振仪、高分辨质谱、傅立叶变换红外光谱等对合成的产物跟踪表征。结果缩短了反应时间,提高了反应产率,可以达到较好修饰效果,确定了目标产物反应的最佳条件。结论两种修饰方式的协同作用可以有效的解决天然喜树碱溶解性差,母体毒副作用大的缺点。 Aim To improve the solubility and anti-tumor activity of camptothecin.Method A new synthesis path of conversion of camptothecin to 7-ethylcamptothecin was used,then aspirin modifier 7-ethylcamptothecin was used,by means of ^1HNMR,MS,FT-IR analysis.Results The reaction time has been greatly shortened and the yield of products has been improved.Optimized and improved reaction condition has been adopted.Conclusion Two modified form of synergy can effectively solve the poor solubility of camptothecin and the mother of the shortlomings of the side effects.
出处 《安徽医药》 CAS 2008年第9期783-785,共3页 Anhui Medical and Pharmaceutical Journal
关键词 喜树碱 阿司匹林 合成 傅立叶变换红外光谱 产率 camptothecin aspirin synthesis FT-R yield
  • 相关文献

参考文献9

二级参考文献104

  • 1潘显道,王存英.天然抗肿瘤药喜树碱衍生物的研究进展[J].药学学报,2003,38(9):715-720. 被引量:31
  • 2赵健,曹泽毅,廖秦平,周玲,曾毅.阿司匹林对宫颈癌细胞系Caski的生长抑制作用[J].中国妇产科临床杂志,2003,4(1):37-39. 被引量:8
  • 3王浦海,冷宗康,徐军.盐酸拓扑替康的合成及其表征[J].中国药物化学杂志,2004,14(6):350-353. 被引量:2
  • 4何训贵,高河勇,吕伟,蔡俊超.喜树碱及其衍生物的前药研究进展[J].药学进展,2005,29(4):145-150. 被引量:5
  • 5Ikegami T,Ha L,Arimori K,et al.Intestinal alkalization as a possible preventive mechanism in irinotecan (CPT-11)-induced diarrhea[J].Cancer Res,2002,62(1):179-87.
  • 6Ulukan HSwaan PW.Camptothecins:a review of their chemotherapeutic potential[J].Drugs,2002,62(14):2039-57.
  • 7Oguma T.Antitumor drugs possessing topoisomerase I inhibition:applicable separation methods[J].J Chromatogr B Biomed Sci Appl,2001,764(1-2):49-58.
  • 8Laco GS,Collins JR,Luke BT,et al.Human topoisomerase I inhibition:docking camptothecin and derivatives into a structure-based active site model[J].Biochemistry,2002,41(5):1428-35.
  • 9Sanchez-Alcazar JA,Ault JG,Khodjakov A,et al.Increased mitochondrial cytochrome c levels and mitochondrial hyperpolarization precede camptothecin-induced apoptosis in Jurkat cells[J].Cell Death Differ,2000,7(11):1090-100.
  • 10Shao RG,Cao CX,Nieves-Neira W,et al.Activation of the Fas pathway independently of Fas ligand during apoptosis induced by camptothecin in p53 mutant human colon carcinoma cells[J].Oncogene,2001,20(15):1852-9.

共引文献39

同被引文献6

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部